title: Simultaneous measurement of dolasetron and its major metabolite, MDL 74,156, in human plasma and urine.
abstract: A selective and sensitive analytical method for the simultaneous measurement of dolasetron (I) and its major metabolite, MDL 74,156 (II), in human plasma and urine samples has been developed using a structural analogue. MDL 101,858, as internal standard (I.S.). The compounds were extracted from plasma and urine using solvent extraction after the addition of the I.S. Chromatographic separation was carried out on a reversed-phase HPLC column and detection and quantification was by fluorescence with excitation and emission wavelengths of 285 and 345 nm, respectively. Linear responses were obtained over concentration ranges of 5 to 1000 pmol/ml for plasma samples and 20 to 1000 pmol/ml for urine samples with correlation coefficients for the calibration curves exceeding 0.999 in all cases. Intra-day and inter-day reproducibility yielded limits of quantification of 10 pmol/ml for I and 5 pmol/ml for II plasma and 50 pmol/ml for I and II in urine. The method has been applied to the simultaneous analysis of both compounds in plasma and urine samples coming from clinical pharmacokinetic studies.
authors.affiliation: Marion Merrell Dow, Strasbourg, France.
authors.forename: N D
authors.initials: ND
authors.lastname: Huebert
authors.forename: J J
authors.initials: JJ
authors.lastname: Schwartz
authors.forename: L
authors.initials: L
authors.lastname: Zeidler
authors.forename: V
authors.initials: V
authors.lastname: Schwach
authors.forename: K D
authors.initials: KD
authors.lastname: Haegele
mesh_terms: D000438:Alcohols / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D002940:Circadian Rhythm; D005470:Fluorometry; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000737:chemistry / Q000378:metabolism* / Q000652:urine; D007275:Injections, Intravenous; D016014:Linear Models; D009994:Osmolar Concentration; D011807:Quinolizines / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000737:chemistry / Q000378:metabolism* / Q000652:urine; D015203:Reproducibility of Results; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism*; D013997:Time Factors
chemical_list: D000438:Alcohols; D007211:Indoles; D011807:Quinolizines; D012702:Serotonin Antagonists; C060344:dolasetron; C110718:hydrodolasetron